CoChat

Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes

Linnebjerg, H., Kothare, P. A., Skrivanek, Z., de la Peña, A., Atkins, M., Ernest, C. S., Trautmann, M. E. · 2006 · Diabetic Medicine
Cited by 48

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Aims Exenatide is an incretin mimetic whose effect on glycaemic control in patients with Type 2 diabetes is currently under investigation. This study assessed the effect of injection time relative to a standardized meal on postprandial pharmacodynamics of exenatide in patients with Type 2 diabetes. Methods Eighteen patients participated in this single‐centre, open‐label, placebo‐controlled, randomized, six‐way crossover study. Patients received subcutaneous injections of either placebo (−15 min) or 10 µg of exenatide at −60, −15, 0, +30 or +60 min relative to a standardized breakfast meal on six consecutive days. Serial blood samples were assayed for plasma glucose and insulin concentrations. Results For all exenatide treatments, incremental postprandial glucose area under the postprandial plasma glucose curve from zero to 6 h (AUC 0−6 h) was significantly reduced compared with placebo. When exenatide was administered before (−60, −15 min) or with the meal (0 min), peak postprandial glucose concentrations were significantly decreased (P < 0.0001 for all treatments) compared with placebo. Post‐meal exenatide administration (+30, P < 0.05; +60 min, P = 0.21) resulted in smaller peak glucose reductions and in some patients transient low plasma glucose concentrations were reported. Peak plasma insulin concentrations in the pre‐meal treatments were significantly lower than placebo (P < 0.05 for all treatments), while post‐meal dosing groups exhibited a trend towards higher insulin peaks compared with placebo. The most common adverse events related to exenatide were headache, nausea, dyspepsia and vomiting, and were generally of mild‐to‐moderate intensity. Conclusions In this study, all exenatide treatments demonstrated reductions in postprandial plasma glucose excursions compared with placebo. Pre‐meal and with meal administration of exenatide produced greater reduction of postprandial glucose excursions compared with post‐meal administration. These data support flexible dosing of exenatide at any time within 60 min before a meal.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2006.01800.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 48

Metadata

Authors
Linnebjerg, H., Kothare, P. A., Skrivanek, Z., de la Peña, A., Atkins, M., Ernest, C. S., & Trautmann, M. E.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2006-02-16
Volume
23
Issue
3
Pages
240-245
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2103266155
Cited by
48
References
6
FWCI
4.44
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.